Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ELFABRIO ® safely and effectively. See full prescribing information for ELFABRIO . ELFABRI O ( pegunigalsidase alfa - iwxj ) injection, for intravenous use Initial U.S. Approval: 2023
Medication labelWhy this: Advisory · dailymed-prescription
ELFABRIO is indicated for the treatment of adults with confirmed Fabry disease.
- generic_name
- pegunigalsidase alfa
- product_names
- pegunigalsidase alfa
- ndc
- 10122-160, 10122-160-01, 10122-160-02, 10122-160-05, 10122-160-10, 10122-165, 10122-165-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en